Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
Recorded changes
86,510 on record
Recorded policy changes, newest first| Recorded | Payer | Policy | Change |
|---|
| May 18, 2026 | Regence BCBS | Occipital Nerve StimulationPayerPolicy · REGENCE-SUR174 | Criteria changed |
|---|
| May 18, 2026 | Regence BCBS | New and Emerging Medical Technologies and ProceduresPayerPolicy · REGENCE-MED149 | Criteria changed |
|---|
| May 18, 2026 | Regence BCBS | Nerve Graft with Radical ProstatectomyPayerPolicy · REGENCE-SUR117 | Criteria changed |
|---|
| May 18, 2026 | Regence BCBS | Negative Pressure Wound Therapy in the Outpatient SettingPayerPolicy · REGENCE-DME42 | Criteria changed |
|---|
| May 18, 2026 | Regence BCBS | Microcurrent Stimulation (MENS)PayerPolicy · REGENCE-DME83.03 | Criteria changed |
|---|
| May 18, 2026 | Regence BCBS | Mechanical Residual Limb Volume Management System for Upper Extremity ProsthesesPayerPolicy · REGENCE-DME98 | Criteria changed |
|---|
| May 18, 2026 | Regence BCBS | Measurement of Serum Antibodies to Selected Biologic AgentsPayerPolicy · REGENCE-LAB65 | Criteria changed |
|---|
| May 18, 2026 | Regence BCBS | Measurement of Exhaled Breath Condensates in the Diagnosis and Management of Other Respiratory DisordersPayerPolicy · REGENCE-MED108 | Criteria changed |
|---|
| May 18, 2026 | Regence BCBS | Manipulation Under AnesthesiaPayerPolicy · REGENCE-MED130 | Criteria changed |
|---|
| May 18, 2026 | Regence BCBS | Magnetic Esophageal Ring to Treat Gastroesophageal Reflux Disease (GERD)PayerPolicy · REGENCE-SUR190 | Criteria changed |
|---|
| May 18, 2026 | Regence BCBS | Lung and Lobar Lung TransplantPayerPolicy · REGENCE-TRA08 | Criteria changed |
|---|
| May 18, 2026 | Regence BCBS | Low-Level Laser TherapyPayerPolicy · REGENCE-MED105 | Criteria changed |
|---|
| May 18, 2026 | Regence BCBS | Left-Atrial Appendage Closure Devices for Stroke Prevention in Atrial FibrillationPayerPolicy · REGENCE-SUR195 | Criteria changed |
|---|
| May 18, 2026 | Regence BCBS | Laser Treatment for Port Wine StainsPayerPolicy · REGENCE-SUR12.34 | Criteria changed |
|---|
| May 18, 2026 | Regence BCBS | Laboratory Tests for Organ Transplant RejectionPayerPolicy · REGENCE-LAB51 | Criteria changed |
|---|
| May 18, 2026 | Regence BCBS | KRAS, NRAS, and BRAF Variant Analysis and MicroRNA Expression Testing for Colorectal CancerPayerPolicy · REGENCE-GT13 | Criteria changed |
|---|
| May 18, 2026 | Regence BCBS | Knee SurgeriesPayerPolicy · REGENCE-SUR229 | Criteria changed |
|---|
| May 18, 2026 | Regence BCBS | Islet TransplantationPayerPolicy · REGENCE-TRA13 | Criteria changed |
|---|
| May 18, 2026 | Regence BCBS | Irreversible ElectroporationPayerPolicy · REGENCE-SUR242 | Criteria changed |
|---|
| May 18, 2026 | Regence BCBS | Invasive Prenatal Fetal Diagnostic Testing Using Chromosomal AbnormalitiesPayerPolicy · REGENCE-GT78 | Criteria changed |
|---|
| May 18, 2026 | Regence BCBS | Interspinous and Interlaminar Stabilization and Distraction Devices (Spacers)PayerPolicy · REGENCE-SUR155 | Criteria changed |
|---|
| May 18, 2026 | Regence BCBS | Interferential Current StimulationPayerPolicy · REGENCE-DME83.07 | Criteria changed |
|---|
| May 18, 2026 | Regence BCBS | Intensity Modulated Radiotherapy (IMRT) of the Thorax, Abdomen, Pelvis, and ExtremitiesPayerPolicy · REGENCE-MED165 | Criteria changed |
|---|
| May 18, 2026 | Regence BCBS | Intensity Modulated Radiotherapy (IMRT) of the Central Nervous System (CNS), Head, Neck, and ThyroidPayerPolicy · REGENCE-MED164 | Criteria changed |
|---|
| May 18, 2026 | Regence BCBS | Intensity Modulated Radiotherapy (IMRT) for Tumors in Close Proximity to Organs at RiskPayerPolicy · REGENCE-MED167 | Criteria changed |
|---|
| May 18, 2026 | Regence BCBS | Intensity Modulated Radiotherapy (IMRT) for Breast CancerPayerPolicy · REGENCE-MED166 | Criteria changed |
|---|
| May 18, 2026 | Regence BCBS | Insulin Infusion Pumps, Automated Insulin Delivery and Artificial Pancreas Device SystemsPayerPolicy · REGENCE-DME77 | Criteria changed |
|---|
| May 18, 2026 | Regence BCBS | In Vivo Analysis of Colorectal LesionsPayerPolicy · REGENCE-MED104 | Criteria changed |
|---|
| May 18, 2026 | Regence BCBS | In Vitro Chemoresistance and Chemosensitivity AssaysPayerPolicy · REGENCE-LAB06 | Criteria changed |
|---|
| May 18, 2026 | Regence BCBS | Implantable Peripheral Nerve Stimulation and Peripheral Subcutaneous Field StimulationPayerPolicy · REGENCE-SUR205 | Criteria changed |
|---|
| May 18, 2026 | Regence BCBS | IDH1 and IDH2 Genetic Testing for Conditions Other Than Myeloid Neoplasms or LeukemiaPayerPolicy · REGENCE-GT19 | Criteria changed |
|---|
| May 18, 2026 | Regence BCBS | Identification of Microorganisms Using Nucleic Acid ProbesPayerPolicy · REGENCE-GT85 | Criteria changed |
|---|
| May 18, 2026 | Regence BCBS | Hyperoxemic Reperfusion ThearpyPayerPolicy · REGENCE-MED173 | Criteria changed |
|---|
| May 18, 2026 | Regence BCBS | Hematopoietic Cell Transplantation in the Treatment of Germ-Cell TumorsPayerPolicy · REGENCE-TRA45.38 | Criteria changed |
|---|
| May 18, 2026 | Regence BCBS | Hematopoietic Cell Transplantation for Non-Hodgkin's LymphomasPayerPolicy · REGENCE-TRA45.23 | Criteria changed |
|---|
| May 18, 2026 | Regence BCBS | Hematopoietic Cell Transplantation for Hodgkin LymphomaPayerPolicy · REGENCE-TRA45.30 | Criteria changed |
|---|
| May 18, 2026 | Regence BCBS | Hematopoietic Cell Transplantation for Chronic Lymphocytic Leukemia and Small Lymphocytic LymphomaPayerPolicy · REGENCE-TRA45.35 | Criteria changed |
|---|
| May 18, 2026 | Regence BCBS | Hematopoietic Cell Transplantation for Central Nervous System Embryonal Tumors and EpendymomaPayerPolicy · REGENCE-TRA45.33 | Criteria changed |
|---|
| May 18, 2026 | Regence BCBS | Hematopoietic Cell Transplantation for Acute Myeloid LeukemiaPayerPolicy · REGENCE-TRA45.28 | Criteria changed |
|---|
| May 18, 2026 | Regence BCBS | Hematopoietic Cell Transplantation for Acute Lymphoblastic LeukemiaPayerPolicy · REGENCE-TRA45.36 | Criteria changed |
|---|
| May 18, 2026 | Regence BCBS | Heart-Lung TransplantPayerPolicy · REGENCE-TRA03 | Criteria changed |
|---|
| May 18, 2026 | Regence BCBS | H-wave StimulationPayerPolicy · REGENCE-DME83.02 | Criteria changed |
|---|
| May 18, 2026 | Regence BCBS | Genetic Testing for the Evaluation of Products of Conception and Pregnancy LossPayerPolicy · REGENCE-GT79 | Criteria changed |
|---|
| May 18, 2026 | Regence BCBS | Genetic Testing for Statin-Induced MyopathyPayerPolicy · REGENCE-GT50 | Criteria changed |
|---|
| May 18, 2026 | Regence BCBS | Genetic Testing for Neurofibromatosis Type 1 or 2PayerPolicy · REGENCE-GT84 | Criteria changed |
|---|
| May 18, 2026 | Regence BCBS | Genetic Testing for Myeloid Neoplasms and LeukemiaPayerPolicy · REGENCE-GT59 | Criteria changed |
|---|
| May 18, 2026 | Regence BCBS | Genetic Testing for Heritable Disorders of Connective TissuePayerPolicy · REGENCE-GT77 | Criteria changed |
|---|
| May 18, 2026 | Regence BCBS | Genetic Testing for Familial HypercholesterolemiaPayerPolicy · REGENCE-GT11 | Criteria changed |
|---|
| May 18, 2026 | Regence BCBS | Genetic Testing for Duchenne and Becker Muscular DystrophyPayerPolicy · REGENCE-GT69 | Criteria changed |
|---|
| May 18, 2026 | Regence BCBS | Genetic Testing for Diagnosis and Management of Behavioral Health ConditionsPayerPolicy · REGENCE-GT53 | Criteria changed |
|---|